News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kathleen A. Fairman, MA

Articles by Kathleen A. Fairman, MA

Utilization Outcomes and Patient Cost Sharing

ByKathleen A. Fairman, MA,Michael E. Chernew, PhD,Joseph P. Newhouse, PhD

September 14th 2008

Course of Antidepressant Treatment with Tricyclic Versus Selective Serotonin Reuptake Inhibitor Agents: A Comparison in Managed Care and Fee-for-Service Environments

ByKathleen A. Fairman, MA,Fred Teitelbaum, PhD,Wayne C. Drevets, MD,Gretchen Engquist, PhD,Jerold J. Kresman, MD,Marija J. Norusis, PhD

March 1st 1997

Latest Updated Articles

Course of Antidepressant Treatment with Tricyclic Versus Selective Serotonin Reuptake Inhibitor Agents: A Comparison in Managed Care and Fee-for-Service Environments
Published: March 1st 1997 | Updated:
Utilization Outcomes and Patient Cost Sharing
Published: September 14th 2008 | Updated:

Trending on AJMC

FDA to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads

Contributor: Reimagining Beneficiary Engagement in Accountable Care Models to Make America Healthy Again

5 Things to Know About the Oral GLP-1 Era

MID Models Reduce Adverse Events, Lower Costs in Oncology: Kenneth Komorny, PharmD, BCPS

Overcoming Mistrust in Clinical Trial Enrollment Through Community Resources: Susan Vadaparampil, PhD, MPH

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text